Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
560.01
-5.39 (-0.95%)
At close: Jul 9, 2026, 4:00 PM EDT
549.20
-10.81 (-1.93%)
After-hours: Jul 9, 2026, 5:09 PM EDT
Madrigal Pharmaceuticals Market Cap
Madrigal Pharmaceuticals has a market cap or net worth of $12.91 billion as of July 9, 2026. Its market cap has increased by 104.05% in one year.
Market Cap
12.91B
Enterprise Value
12.45B
1-Year Change
104.05%
Ranking
Category
Stock Price
$560.01
Market Cap Chart
Since February 6, 2007, Madrigal Pharmaceuticals's market cap has increased from $297.50M to $12.91B, an increase of 4,239.97%. That is a compound annual growth rate of 21.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 12.91B | -2.38% |
| Dec 31, 2025 | 13.23B | 96.52% |
| Dec 31, 2024 | 6.73B | 47.33% |
| Dec 29, 2023 | 4.57B | -7.98% |
| Dec 30, 2022 | 4.96B | 242.65% |
| Dec 31, 2021 | 1.45B | -15.74% |
| Dec 31, 2020 | 1.72B | 22.31% |
| Dec 31, 2019 | 1.41B | -18.98% |
| Dec 31, 2018 | 1.74B | 51.27% |
| Dec 29, 2017 | 1.15B | 565.31% |
| Dec 30, 2016 | 172.40M | 255.46% |
| Dec 31, 2015 | 48.50M | -83.19% |
| Dec 31, 2014 | 288.60M | -20.30% |
| Dec 31, 2013 | 362.10M | -35.14% |
| Dec 31, 2012 | 558.30M | 141.48% |
| Dec 30, 2011 | 231.20M | -6.85% |
| Dec 31, 2010 | 248.20M | 44.39% |
| Dec 31, 2009 | 171.90M | -17.20% |
| Dec 31, 2008 | 207.60M | -8.55% |
| Dec 31, 2007 | 227.00M | -23.70% |
| Feb 6, 2007 | 297.50M | - |
View and export this data all the way back to 2007. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BridgeBio Pharma | 15.27B |
| Exelixis | 14.35B |
| Ionis Pharmaceuticals | 14.27B |
| Axsome Therapeutics | 12.85B |
| ABIVAX Société Anonyme | 12.49B |
| Summit Therapeutics | 12.33B |
| Arrowhead Pharmaceuticals | 12.25B |
| BioMarin Pharmaceutical | 11.66B |